Skip to main content
. 2022 Sep 5;2022:7324627. doi: 10.1155/2022/7324627

Table 3.

Numerical data of the 23 cases described in the literature of pregnant women with hyperemesis gravidarum treated with mirtazapine.

N Mean Median Minimum Maximum Percentiles
Valid Omit 25 50 75
Age (years) 22 1 30.45 31.00 20 38 28 31 34
Gestational age (weeks) 23 0 12.30 11.00 5 25 9.00 11.00 15.00
Gesta 21 2 2.48 2.00 1 6 1.0 2.0 3.5
Para 21 2 0.71 1.00 0 2 0 1.0 1.0
Abortion 21 2 0.76 0 0 4 0 0 1
Weight loss (kg) 8 15 7.60 7.00 2.5 13.0 3.500 7.000 11.825
Initial dose (mg/day) 23 0 15.3587 15 3.75 30 7.5 15 15
Effective dose (mg/day) 22 1 20.2841 15 3.75 45 15 15 30
Days for clinical improvement (days) 14 9 4.14 3 1 14 2.00 3.00 4.25
Treatment time (days) 12 11 56.50 21 2 210 6.75 21 119
Number of antiemetics 16 7 2.88 3.0 1 6 2 3 4
Gestational age at birth (weeks) 15 8 37.07 37 30 40 35 37 40
Newborn weight (grams) 8 15 2644.63 3204.50 1102 3550 1647.50 3204.50 3329.50